Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Class 2 Drug Alert (action within 48 hours): Bristol Laboratories Ltd - Warfarin Tablets 1mg - EL(07)A/16

Document details:

Type: Drug Alert
Series No: EL(07)A/16
Audience: Healthcare professionals
Published:
Format: Electronic and paper
Size: A4
Pages: 1
Price: Free
ISBN/ISSN:
Author:
Copyright: Crown
   

Help viewing PDFs:

DRUG ALERT

Class 2 medicines recall
Action within 48 hours
Pharmacy (or equivalent) level recall
15 October 2007 EL(07)A/16 Our ref:  MDR 08-09/07

Dear Healthcare Professional,

Bristol Laboratories Ltd

Warfarin Tablets 1mg

PL 17907/0103

Batch number

Expiry

Pack size

First distributed

BYB7003F

April 2009

28

6 August 2007

BYB7004F

April 2009

28

6 August 2007


Bristol Laboratories Ltd are voluntarily recalling the above products. The tablets are peach coloured and packaged in a pink carton. The product complies with the granted product licence but not with the voluntary code of practice for Warfarin 1mg tablets with brown tablets in cartons with brown identifiers.

Recipients are requested to quarantine any remaining stock and return it to their supplier for credit.

For further information please telephone Mr P.M. Raju at Bristol Laboratories on 01442 200922.

Recipients of this Drug Alert should bring this information to the attention of relevant contacts by copy of this letter. Primary Care Trusts are asked to bring this information to the attention of relevant clinics, General Practitioners and Community Pharmacists by copy of this letter.

Yours faithfully,

Ian Holloway

DMRC Manager

MHRA Distribution (further recipients by cascade):

Regional Contacts for NHS Trusts and Provider Units
Chief Pharmacists: England, Scotland, Wales, Northern Ireland
Prison Health Policy Unit (DH)
Medical Supplies Agency (MOD)
Chief Pharmacists: Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar
Special Hospitals
Healthcare Commission for distribution to Independent Health Care Establishments

Page last modified: 15 October 2007